Areas of interest

Pelvic organ prolapse (POP)

Research group

Translational Tissue Engineering

Biography

Dr Kallyanashis Paul is a post-doctoral researcher in the Translational Tissue Engineering lab. Dr Paul demonstrated a versatile skill set across hard and soft tissue regenerative engineering due to his passion for bio-fabrication. His versatile skill set was learned through his PhD in regenerative medicine (Monash University, Australia), a research master’s study in Regenerative Bone Tissue Engineering (SCH, South Korea) and a bachelor’s study in Industrial and Production Engineering (BUET, Bangladesh), followed by industrial work experience (5 years+). Engineers Australia acknowledged his outstanding engineering skill set through the certification as a professional industrial engineer (Skill level 1, ANZSCO code 233511). He is an expert in modulating surface architecture for intended tissue regenerative applications. He pioneered the world’s first uterine-stem-cell-boosted-3D-printed-construct to treat POP. Dr Paul is leading the development of clinically relevant translational constructs for treating pelvic organ prolapse. In parallel, he is developing prognostic 3D models in vitro for cancer and pelvic organ prolapse research, which will be instrumental in developing next-generation precision medicine. He has reported 7 distinct prototypes to solve critical health burdens for aged people, including pelvic organ prolapse (POP), osteoporosis, and large segmental bone defects.

His outstanding research awarded him the Veski Fellowship 2021, runner-up in the Prestigious Victorian Premier’s Awards for Health and Medical Research (clinical researcher category) and multiple prestigious grants as chief investigator, including the Jack Brockhoff Foundation ECR grant, the CASS Foundation Medicine/Science grant and MRFF early to mid-career researcher grant.

Dr Paul’s current research projects are below:

1. Develop clinically relevant 3D Printed regenerative constructs for soft tissue (Pelvic Organ Prolapse) and hard tissue (Bone abnormalities) regeneration.
2. Develop 3D Printed multicellular In vitro models for cancer research and define strategies for 3D culture.
3. Develop cell-free bioactive 3D Printed constructs for tissue regenerative applications.